Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol SLC16A4 contributors: mct - updated : 07-04-2020
HGNC name solute carrier family 16, member 4 (monocarboxylic acid transporter 5)
HGNC id 10925
Location 1p13.3      Physical location : 110.905.504 - 110.933.636
Synonym name
  • solute carrier family 16 (monocarboxylic acid transporters), member 4
  • monocarboxylate transporter 4
  • monocarboxylate transporter 5
  • Synonym symbol(s) MCT4, MCT5
    DNA
    TYPE functioning gene
    STRUCTURE 29.12 kb     9 Exon(s)
    Genomic sequence alignment details
    10 Kb 5' upstream gene genomic sequence study
    MAPPING cloned Y linked N status provisional
    RNA
    TRANSCRIPTS type messenger
    identificationnb exonstypebpproduct
    ProteinkDaAAspecific expressionYearPubmed
    9 - 2529 - 487 - 2019 31101938
    8 - 2496 - 425 - 2019 31101938
    8 - 2423 - 439 - 2019 31101938
    7 - 2372 - 382 - 2019 31101938
    7 - 1930 - 257 - 2019 31101938
    8 - 2063 - 319 - 2019 31101938
    EXPRESSION
    Type widely
       expressed in (based on citations)
    organ(s)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    Hearing/Equilibriumearinnercochlea highly
    Nervousbrain     Homo sapiens
    Reproductivefemale systemplacenta  highly
    Urinarykidney   highly
    Visualeyeanterior segmentcornea   Homo sapiens
    tissue
    SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
    Connectiveadipose    Homo sapiens
    Muscularstriatumskeletal   Homo sapiens
    cells
    SystemCellPubmedSpeciesStageRna symbol
    Blood/Hematopoieticerythrocyte Homo sapiens
    Visualepithelial cell Homo sapiens
    cell lineage
    cell lines
    fluid/secretion
    at STAGE
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
  • twelve transmembrane spanning segments with a cytoplasmic loop between TM6 and TM7 ( Arg-278 in TMD8 is a critical residue involved in substrate, L-lactate recognition by SLC16A4)
  • HOMOLOGY
    Homologene
    FAMILY
  • major facilitator superfamily
  • monocarboxylate porter family
  • CATEGORY transport carrier
    SUBCELLULAR LOCALIZATION     plasma membrane
    basic FUNCTION
  • catalyzing the rapid transport across the plasma membrane of many monocarboxylates such as lactate, pyruvate, branched-chain oxo acids derived from leucine, valine and isoleucine
  • specific interaction of SLC16A4 with beta(1)-integrin may regulate cell migration through modulation of focal adhesions
  • mediates lactic acid efflux from most tissues that are dependent on glycolysis for their ATP production
  • hypoxia stimulates lactate release and modulates monocarboxylate transporter (SLC16A1, SLC16A2, and SLC16A4) expression in human adipocytes
  • critical role of SLC16A4 in cell proliferation and metastasis in oral squamous cell carcinoma
  • SLC16A4 up-regulation represents a positive feedback mechanism in macrophages to maintain a high glycolytic rate that is essential to a fully activated inflammatory response
  • lactate homeostasis participates in the regulation of the Schwann cells (SCs) myelination program and reveal that similar to CNS, PNS axon-glial metabolic interactions are most likely mediated by SLC16A4, SLC16A1
  • shows highly specific substrate recognition and low-affinity l-lactate transport
  • mediate L-lactate transport
  • is a critical element for glycolytic metabolism and malignant behaviors in many tumor cells 3)
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    text monocarboxylate transport
    PATHWAY
    metabolism monocarbon
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
  • proton linked
  • protein
  • BSG is required for the expression of SLC16A1 and SLC16A4 in the corneal endothelium
  • is required for macrophage activation upon TLR2 and TLR4 stimulations
  • TMPRSS11B promotes solubilization of BSG, an obligate chaperone of SLC16A4, which enhances lactate export and glycolytic metabolism, thereby promoting tumorigenesis
  • TMPRSS11B interacts with BSG and SLC16A4 at the plasma membrane
  • cell & other
    REGULATION
    activated by by hypoxia through a HIF-1alpha-mediated mechanism
    Other SLC16A4, SLC16A1 are regulated via expression of their chaperone, BSG
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in osteosarcoma tissues compared with that in adjacent normal ones, and may predict poor prognosis among osteosarcoma patients
    tumoral     --over  
    in urothelial carcinoma is associated with features of aggressive tumor biology and portends a poor prognosis
    tumoral     --over  
    is highly overexpressed in malignant cells of acsites in gastric carcinoma
    constitutional     --low  
    reduced SLC16A4 and SLC1A3 expression by astrocytes may lead to neuronal hyperexcitability and epileptogenesis in the temporal lobe by reducing the supply of metabolic intermediates and by allowing accumulation of extracellular glutamate
    tumoral     --over  
    SLC16A44 and BSG overexpression correlated with higher PSA levels, as well as with perineural invasion and biochemical recurrence in prostate carcinoma
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
  • may represent for colorectal cancer with peritoneal carcinomatosis a prognostic indicator
  • is prognostic biomarker for clear cell renal cell carcinoma (ccRCC)
  • Therapy target
    SystemTypeDisorderPubmed
    cancer  
    pharmacological inhibition of SLC16A1 and SLC16A4 combined with metformin treatment is a potential cancer therapy
    cancerurinary 
    targeting lactate metabolism via SLC16A4 provides a promising therapeutic approach for invasive urothelial carcinoma, especially in the basal subtype
    cancerdigestivecolon
    may represent a new therapeutic target for colorectal cancer with peritoneal carcinomatosis
    cancerdigestivestomach
    is a clinically relevant therapy target in GC with peritoneal carcinomatosis
    ANIMAL & CELL MODELS